GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (ASX:EBO) » Definitions » Beneish M-Score

Ebos Group (ASX:EBO) Beneish M-Score : -2.58 (As of Apr. 26, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Ebos Group Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.58 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Ebos Group's Beneish M-Score or its related term are showing as below:

ASX:EBO' s Beneish M-Score Range Over the Past 10 Years
Min: -2.65   Med: -2.46   Max: -1.01
Current: -2.58

During the past 13 years, the highest Beneish M-Score of Ebos Group was -1.01. The lowest was -2.65. And the median was -2.46.


Ebos Group Beneish M-Score Historical Data

The historical data trend for Ebos Group's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Beneish M-Score Chart

Ebos Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.53 -2.33 -2.50 -2.23 -2.58

Ebos Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.23 - -2.58 -

Competitive Comparison of Ebos Group's Beneish M-Score

For the Medical Distribution subindustry, Ebos Group's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ebos Group's Beneish M-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Ebos Group's Beneish M-Score falls into.



Ebos Group Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Ebos Group for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9555+0.528 * 0.9094+0.404 * 1.0276+0.892 * 1.1314+0.115 * 0.7822
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1065+4.679 * -0.019181-0.327 * 0.9896
=-2.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun23) TTM:Last Year (Jun22) TTM:
Total Receivables was A$1,490 Mil.
Revenue was A$12,174 Mil.
Gross Profit was A$1,553 Mil.
Total Current Assets was A$2,991 Mil.
Total Assets was A$6,403 Mil.
Property, Plant and Equipment(Net PPE) was A$657 Mil.
Depreciation, Depletion and Amortization(DDA) was A$124 Mil.
Selling, General, & Admin. Expense(SGA) was A$529 Mil.
Total Current Liabilities was A$2,644 Mil.
Long-Term Debt & Capital Lease Obligation was A$1,184 Mil.
Net Income was A$252 Mil.
Gross Profit was A$-14 Mil.
Cash Flow from Operations was A$389 Mil.
Total Receivables was A$1,378 Mil.
Revenue was A$10,760 Mil.
Gross Profit was A$1,248 Mil.
Total Current Assets was A$3,072 Mil.
Total Assets was A$6,280 Mil.
Property, Plant and Equipment(Net PPE) was A$578 Mil.
Depreciation, Depletion and Amortization(DDA) was A$82 Mil.
Selling, General, & Admin. Expense(SGA) was A$422 Mil.
Total Current Liabilities was A$2,518 Mil.
Long-Term Debt & Capital Lease Obligation was A$1,277 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1489.72 / 12173.616) / (1378.033 / 10759.899)
=0.122373 / 0.128071
=0.9555

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1248.256 / 10759.899) / (1552.996 / 12173.616)
=0.11601 / 0.127571
=0.9094

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2991.204 + 657.232) / 6403.482) / (1 - (3072.016 + 578.363) / 6279.591)
=0.430242 / 0.418692
=1.0276

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=12173.616 / 10759.899
=1.1314

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(82.068 / (82.068 + 578.363)) / (124.133 / (124.133 + 657.232))
=0.124264 / 0.158867
=0.7822

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(528.608 / 12173.616) / (422.249 / 10759.899)
=0.043422 / 0.039243
=1.1065

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1184.47 + 2644.199) / 6403.482) / ((1276.521 + 2517.662) / 6279.591)
=0.597904 / 0.604209
=0.9896

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(252.052 - -14.46 - 389.336) / 6403.482
=-0.019181

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Ebos Group has a M-score of -2.57 suggests that the company is unlikely to be a manipulator.


Ebos Group Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Ebos Group's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Ebos Group (ASX:EBO) Business Description

Traded in Other Exchanges
Address
108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (ASX:EBO) Headlines

No Headlines